Discover and read the best of Twitter Threads about #cancerscreening

Most recents (7)

@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 2/ ๐Ÿ“ธ Faculty disclosures & CME certification โ„น ๐Ÿ‘‡
#CME certificate ๐Ÿ… โ†’ โ„น๏ธ bit.ly/3GOowNG Image
@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 3/ ๐Ÿ‘Œlet's ๐Ÿšด

In addition to ๐Ÿ’‰, pts w #IBD should undergo regular #PreventiveHealth #HCM:
๐Ÿ“ŒCancer Screening ๐Ÿฆ€
๐Ÿ“ŒBone Health assessment ๐Ÿฆด
๐Ÿ“ŒMental Health ๐Ÿฅบ
๐Ÿ“ŒTreatment specific Testing ๐Ÿ’‰๐Ÿ’Š
๐Ÿ“ŒNutrition
๐Ÿ“ŒSmoking cessation ๐Ÿšฌ

#ICYMI vaccines #MNIBDTweetorial ๐Ÿ“Ž @๐Ÿ”š of ๐Ÿงต Image
@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 4/ ๐ŸงฉWho is IS? #IBD pts on or had within last 3 months:
๐Ÿšฉ Prednisone > 20mg/day >2wks
๐Ÿšฉ AZA >2.5 mg/kg/day
๐Ÿšฉ 6MP >1.5 mg/kg/day
๐Ÿšฉ MTX >0.4 mg/kg/week
๐Ÿšฉ Cyclosporine
๐Ÿšฉ Tacrolimus
๐Ÿšฉ Tofacitinib, ozanimod
๐Ÿšฉ TNFi, UST

Also:
๐Ÿšฉ Significant protein-calorie malnutrition
Read 22 tweets
In #biotech #stocks, more market jitters at NASDAQ opening, all biotech stocks down except for $ONT.L Oxford @nanopore and $NEO NeoGenomics Image
$ONT.L Oxford @nanopore floated on Wednesday, today still on a steady uphill. Trades in London stock exchange, so off by 4-5 hours US East time. Image
$NEO NeoGenomics has been on a tear in the last few days. A company growing both organically and by acquisition, aggressively positioning itself in the #LiquidBiopsy #CancerScreening segment. Image
Read 4 tweets
Two large #antitrust probes in the same screenshot that relate to #Genomics and #Bioinformatics
(1) Possible buyout of #ARM by #NVIDIA does have an effect on the #Bioinformatics field: many applications now are deployable on CPU/GPUs with #ARM and/or #NVIDIA chips on them. Some recent examples are:
(a) the Oxford @nanopore MinION Mk1c device, which originally was specced at Jetson TX2 ARM+Pascal GPU accelerators (ARM processor 6 cores, 256 Core GPU), 8 GB RAM (may have changed since then.
Read 42 tweets
A more polished thread on #epigenomic #biomarkers for #LiquidBiopsy and #CancerScreening:
Epigenomic biomarkers are becoming more established for #LiquidBiopsy and #CancerScreening, and we have seen the big players positioning themselves in this #epigenomics race recently.
Catching signs of #cancer early is crucially important to the disease management and survival rates, so the question is: how can we find out if there is something wrong going on early enough, ideally in a low-cost assay that can be performed regularly on healthy individuals?
Read 39 tweets
@sbarnettARK Epigenomic biomarkers are becoming more established for #LiquidBiopsy and #CancerScreening, and we have seen the big players positioning themselves in this #epigenomics race recently.
@sbarnettARK Catching signs of #cancer early is crucially important to the disease management and survival rates, so the question is: how can we find out if there is something wrong going on early enough?
@sbarnettARK The first generation of high-throughput technologies was predicated on finding mutated (tumor) DNA in the individual's body (somatic), different from their (normal) DNA. Tumor/Normal (T/N) comparisons of the individual's samples, biopsies or ctDNA will indicate if there
Read 38 tweets
1/13 Really interesting read Rory. Thx for sharing. I agree, its v difficult to remain clear headed when theres so much data & it can all be interpreted in different ways. Prof. @AndrewEwing11 is unhappy with #Sweden's strategy and has been openly critical - he's entitled to that
2/13 I think that data is being represented in a way that suits the narrative.I added extra columns:"since Aug 7" & "since Sept 7".I used Oct 14 as end point (date of publication).I also highlighted Netherlands in red as it was best performing in the table and good for comparison
3/13 In Sweden from Aug to Oct there was a 3% increase in cumulative deaths per 100k and from Sept to Oct there was a 1% increase. Meanwhile, Netherlands (best of the worst) had 8% & 6% increases in cumulative deaths per 100k respectively.
Read 13 tweets
October is Breast Cancer Awareness month.

I wish to update everyone on the role we play in early detection and treatment for women affected by this terrible disease.

#breastcancer #October #breastcancerawareness #Pune #dentist #cancerscreening
As part of my training at the University of Pennsylvania, we were taught the role of regular Oral Cancer Screening to be carried out at each visit.

The mandible is the most common site for metastasis aka secondary spread of Breast Cancer.
As such we contribute both towards primary diagnosis and ruling out recurrence. A simple panoramic xray is generally sufficient in most cases.

If a patient is to undergo Chemotherapy, it becomes very important to eliminate all potential sources of infection.
Read 6 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!